Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients

NCT02062489 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

688

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen
DRUG: Placebo

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University